Home LiteratureArticle Details
PMID: 3492487 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Ciprofloxacin and co-trimoxazole in urinary tract infection.

The Journal of antimicrobial chemotherapy ·Vol. 18 Suppl D ·1986-11-00 ·Pages 107-10

Williams AH, Grüneberg RN

Abstract

Seventy-five hospital inpatients with bacteriologically confirmed urinary tract infections were allocated to treatment with ciprofloxacin 100 mg, ciprofloxacin 250 mg or co-trimoxazole 960 mg, all given orally twice a day for five days. The patients were generally elderly, with many complicating factors including indwelling catheters; 24% of the infections were caused by Pseudomonas aeruginosa. The cure rates at 28 days were 94%, 88% and 87%, respectively. Side effects were few and minor. Ciprofloxacin appears to be an effective and safe orally-administrable treatment even for complicated urinary tract infection.

MeSH Terms
Adult Aged Aged, 80 and over Anti-Infective Agents, Urinary/therapeutic use Ciprofloxacin/therapeutic use Drug Combinations/therapeutic use Female Humans Male Middle Aged Random Allocation Sulfamethoxazole/therapeutic use Trimethoprim/therapeutic use Trimethoprim, Sulfamethoxazole Drug Combination Urinary Tract Infections/drug therapy
Chemicals
Anti-Infective Agents, Urinary Drug Combinations Ciprofloxacin Trimethoprim, Sulfamethoxazole Drug Combination Trimethoprim Sulfamethoxazole
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Williams A H
Grüneberg R N
Article Info
Journal
The Journal of antimicrobial chemotherapy
Abbr.
J Antimicrob Chemother
ISSN
0305-7453
Published
1986-11-00
Pages
107-10
Language
English
Region
England
NLM ID
7513617
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]